Skip to main content

Peer Review reports

From: Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis

Original Submission
26 Feb 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
17 Apr 2024 Reviewed Reviewer Report
14 May 2024 Reviewed Reviewer Report
14 May 2024 Reviewed Reviewer Report
11 Jun 2024 Author responded Author comments - Hamidreza Soleimani
Resubmission - Version 3
11 Jun 2024 Submitted Manuscript version 3
23 Jun 2024 Reviewed Reviewer Report
27 Jun 2024 Reviewed Reviewer Report
5 Jul 2024 Author responded Author comments - Hamidreza Soleimani
Resubmission - Version 4
5 Jul 2024 Submitted Manuscript version 4
8 Jul 2024 Reviewed Reviewer Report
11 Jul 2024 Reviewed Reviewer Report
12 Jul 2024 Author responded Author comments - Hamidreza Soleimani
Resubmission - Version 5
12 Jul 2024 Submitted Manuscript version 5
15 Jul 2024 Reviewed Reviewer Report
15 Jul 2024 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
16 Jul 2024 Editorially accepted
30 Jul 2024 Article published 10.1186/s12872-024-04057-w

You can find further information about peer review here.

Back to article page